CARRIERE STEPHEN J 4
4 · Evelo Biosciences, Inc. · Filed Jan 23, 2023
Insider Transaction Report
Form 4
CARRIERE STEPHEN J
Principal Accounting Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-01-19−354→ 1,063 totalExercise: $0.00Exp: 2032-01-19→ Common Stock (354 underlying) - Exercise/Conversion
Common Stock
2023-01-19+354→ 354 total - Sale
Common Stock
2023-01-23$1.06/sh−151$160→ 203 total
Footnotes (5)
- [F1]Settlement of shares of Common Stock acquired upon the vesting of Restricted Stock Units previously granted to the reporting person.
- [F2]The price is N/A.
- [F3]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units previously granted to the reporting person. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.06 to $1.0712, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.
- [F5]The Restricted Stock Units vest in four substantially equal annual installments at the end of each annual anniversary of the date of grant, subject to continued employment on such dates.